Literature DB >> 22202704

Intravenous immunoglobulins prevent the breakdown of the blood-brain barrier in experimentally induced sepsis.

Figen Esen1, Evren Senturk, Perihan E Ozcan, Bulent Ahishali, Nadir Arican, Nurcan Orhan, Oguzhan Ekizoglu, Mutlu Kucuk, Mehmet Kaya.   

Abstract

INTERVENTIONS: The effects of immunoglobulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M on blood-brain barrier integrity and survival rates in septic rats were comparatively investigated. MEASUREMENTS: Sepsis was induced by cecal ligation and perforation in Sprague-Dawley rats. The animals were divided into the following groups: Sham, cecal ligation and perforation, cecal ligation and perforation plus immunoglobulin G (250 mg/kg, intravenous), and cecal ligation and perforation plus immunoglobulins enriched with immunoglobulin A and immunoglobulin M (250 mg/kg, intravenous). Immunoglobulins were administered 5 mins before cecal ligation and perforation and the animals were observed for behavioral changes for 24 hrs following cecal ligation and perforation. Blood-brain barrier permeability was functionally and structurally evaluated by determining the extravasation of Evans Blue and horseradish peroxidase tracers, respectively. Immunohistochemistry and Western blotting for occludin were performed. MAIN
RESULTS: The high mortality rate (34%) noted in the septic rats was decreased to 15% and 3% by immunoglobulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M, respectively (p < .01). Both immunoglobulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M alleviated the symptoms of sickness behavior in the septic rats, with the animals becoming healthy and active. Increased extravasation of Evans Blue into the brain tissue of the septic rats was markedly decreased with the administration of both immunoglobulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M (p < .01). Occludin expression remained essentially unchanged in all groups, including the cecal ligation and perforation group. In the cecal ligation and perforation group, increased luminal and abluminal vesicles containing electron-dense horseradish peroxidase-reaction product were noted in the cytoplasm of endothelial cells located in the hippocampus and the cerebral cortex. Tight junction was ultrastructurally intact, suggesting that the transcellular pathway is responsible for the blood-brain barrier breakdown in sepsis. Following immunoglobulin G or immunoglobulins enriched with immunoglobulin A and immunoglobulin M treatment, no ultrastructural evidence of leaky capillaries in the brain was observed in the septic rats, indicating the blockade of the transcellular pathway by immunoglobulins administration.
CONCLUSIONS: Our study suggests that immunoglobulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M improve the integrity of the blood-brain barrier and inhibits cecal ligation and perforation-induced symptoms of sickness behavior in rats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22202704     DOI: 10.1097/CCM.0b013e31823779ca

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  20 in total

1.  Cooling treatment transiently increases the permeability of brain capillary endothelial cells through translocation of claudin-5.

Authors:  Akinori Inamura; Yasuhiro Adachi; Takao Inoue; Yeting He; Nobuko Tokuda; Takashi Nawata; Satoshi Shirao; Sadahiro Nomura; Masami Fujii; Eiji Ikeda; Yuji Owada; Michiyasu Suzuki
Journal:  Neurochem Res       Date:  2013-05-09       Impact factor: 3.996

2.  Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica.

Authors:  Julien Ratelade; Alex J Smith; A S Verkman
Journal:  Exp Neurol       Date:  2014-03-14       Impact factor: 5.330

Review 3.  Sepsis-Associated Encephalopathy: The Blood-Brain Barrier and the Sphingolipid Rheostat.

Authors:  Stephen J Kuperberg; Raj Wadgaonkar
Journal:  Front Immunol       Date:  2017-06-16       Impact factor: 7.561

Review 4.  Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.

Authors:  Michelle A Erickson; William A Banks
Journal:  Pharmacol Rev       Date:  2018-04       Impact factor: 25.468

5.  Clinical Efficacy of Immunoglobulin Combined with Glucocorticoids in the Treatment of Oculomotor Myasthenia Gravis in Children and the Effect on Serum Immunity.

Authors:  Lijun Fan; Yahui Yang; Fan Zhang; Fei Huang
Journal:  Comput Math Methods Med       Date:  2022-07-08       Impact factor: 2.809

Review 6.  Septic Encephalopathy.

Authors:  Chiara Robba; Ilaria Alice Crippa; Fabio Silvio Taccone
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-02       Impact factor: 5.081

7.  Basic physiology of the blood-brain barrier in health and disease: a brief overview.

Authors:  Mehmet Kaya; Bulent Ahishali
Journal:  Tissue Barriers       Date:  2020-11-15

8.  Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study.

Authors:  Yuk Yee Leung; Jon B Toledo; Alexey Nefedov; Robi Polikar; Nandini Raghavan; Sharon X Xie; Michael Farnum; Tim Schultz; Young Baek; Vivianna V Deerlin; William T Hu; David M Holtzman; Anne M Fagan; Richard J Perrin; Murray Grossman; Holly D Soares; Mitchel A Kling; Matthew Mailman; Steven E Arnold; Vaibhav A Narayan; Virginia M-Y Lee; Leslie M Shaw; David Baker; Gayle M Wittenberg; John Q Trojanowski; Li-San Wang
Journal:  Alzheimers Dement (Amst)       Date:  2015-09-01

9.  Understanding brain dysfunction in sepsis.

Authors:  Romain Sonneville; Franck Verdonk; Camille Rauturier; Isabelle F Klein; Michel Wolff; Djillali Annane; Fabrice Chretien; Tarek Sharshar
Journal:  Ann Intensive Care       Date:  2013-05-29       Impact factor: 6.925

10.  Effects of intravenous immunoglobulin therapy on behavior deficits and functions in sepsis model.

Authors:  Perihan Ergin Ozcan; Evren Senturk; Gunseli Orhun; Salih Gumru; Nadir Arican; Nurcan Orhan; Canan Ugur Yılmaz; Mehmet Kaya; Feyza Aricioglu; Figen Esen
Journal:  Ann Intensive Care       Date:  2015-07-31       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.